TIS tissue therapies limited

relax regarding ce and website, page-13

  1. 492 Posts.
    Hazchem68

    "matt - they have plenty of cash and $40m worth of sales stock.

    they will match expenses with sales - they do not intends to raise capital anywhere around these levels."

    The above is an example of a "blanket ramping statement.". TIS do not have plenty of cash, the retail value of stock is unsold and will likely be sold over the course of 2013, it is not always possible to match expenses with sales - especially when launching a new product, and it is not possible to have absolute control over what price new shares will be issued at.

    Basically risks are being wholly dismissed, somewhat like an ostrich with its head in the sand.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.